Breaking News
British Association of Dermatology compiles new guidelines for azathioprine in inflammatory dermatoses
British Association of Dermatology compiles new guidelines for azathioprine in inflammatory dermatoses
Azathioprine is a well-established thiopurine immunosuppressant prescribed since the 1960s. New guidelines on its use in inflammatory dermatoses have been compiled by the British Association of Dermatology. These were based on the literature published since 1966, and focused especially on the last 5 years. Highlighted recommendations for the practical use of the drug in the clinic, its health economic impact, future directions and updated patient information were discussed (Meggitt, S.J. et al. Br J Dermatol 2011, 165: 711).
Last updated: Tuesday, November 29, 2011
AccessDermatology | © Copyright 2011 Prous Science S.A.U. a Thomson Reuters business or its licensors.
All rights reserved. Legal Information. Send your comments to Webmaster
ISSN 2013-8202
This website is optimized for Explorer 7.0 and above, Firefox 3.0, Safari, and Chrome. Content remains viewable in older versions, but loss of formatting and design elements may occur.
This site complies with the HONcode standard for trustworthy health information:
verify here.